Clinical Trial Update: SurVaxM Expanded Access Protocol

View source ↗

Summary

The expanded access protocol for SurVaxM in glioblastoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• SurVaxM (SurVaxM)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Glioblastoma | Status: NO_LONGER_AVAILABLE